Taiwan-based HCmed appoints new Chief Scientific Officer

Taiwan's HCmed Innovations Co., a contract development and manufacturing organisation (CDMO), ahas nnounced the appointm...

April 11, 2023 | Tuesday | News
Bora Pharmaceuticals and Celltrion partner to expand OSD capabilities in APAC market

Taiwan-based Bora Pharmaceuticals Co. and Celltrion Asia Pacific, a subsidiary of South Korea-based Celltrion Group Inc,...

April 8, 2023 | Saturday | News
Thermo Fisher expands in France to boost capabilities from development to commercial manufacturing

American supplier of scientific instrumentation, reagents and consumables, Thermo Fisher Scientific is adding early deve...

April 8, 2023 | Saturday | News
US CDMOs seek to address capacity challenges and supply chain contingencies

Ahead of a CPHI North America panel discussion – Redesigning the Supply Chain – The Road to I...

April 5, 2023 | Wednesday | News
Bridgewest Group launches new sterile injectable CDMO in Australia

Global private investment firm Bridgewest Group, recognised for developing innovative companies in life sciences, softwa...

April 6, 2023 | Thursday | News
AGC Biologics inks exosome agreement with Jikei University in Japan for Idiopathic Pulmonary Fibrosis project

AGC Biologics, a US-headquartered biopharmaceutical contract development and manufacturing organisation (CDMO), has sign...

April 4, 2023 | Tuesday | News
Takeda Opens its First Platinum Positive Energy Building in Singapore

Takeda has officialy launched its first ‘positive energy’ manufacturing support building at its site in JTC ...

March 30, 2023 | Thursday | Company results
Thermo Fisher opens cell therapy facility at University of California, San Francisco

Thermo Fisher Scientific Inc. and the University of California, San Francisco (UCSF), in the US, will accelerate advance...

March 28, 2023 | Tuesday | News
Korea's Samsung Biologics invests over KRW 1.9 T in new facility

Samsung Biologics, a leading contract development and manufacturing organisation (CDMO) based in South Korea, has announ...

March 17, 2023 | Friday | News
PlasmidFactory announces appointment of Berthold Hackl and Dr Eduard Ayuso to Board of Directors

Leading contract manufacturer and service provider for plasmid and minicircle DNA - PlasmidFactory - has announced the a...

March 14, 2023 | Tuesday | News
Startups in China accelerate development of gene and cell therapy

China-based startups Porton Advanced Solutions and DanausGT Biotechnology have announced a strategic collaboration ...

March 3, 2023 | Friday | News
GenScript expands footprint in Singapore to provide premium gene synthesis service

GenScript Biotech Corporation has announced the expansion of its Singapore facility to provide a premium gene synthesis ...

March 1, 2023 | Wednesday | News
Startups in China accelerate development of innovative cell and gene therapies

China-based startups Porton Advanced Solutions and Yinjia (Shanghai) Biosciences Co. have announced a strategic partners...

February 27, 2023 | Monday | News
Australian firm AcuraBio partners with Cytiva to expand cGMP plasmid DNA CDMO services

AcuraBio, a leading Australian biopharmaceutical contract development and manufacturing organisation (CDMO), will provid...

February 10, 2023 | Friday | News
GenScript ProBio completes nearly $220 M Series C Round of financing in China

GenScript ProBio, a subsidiary of GenScript Biotech Corporation, has announced its Series C round of financing of n...

January 27, 2023 | Friday | News
Korea's Samsung Biologics to continue expansion in capacity, geography and portfolio in 2023

At the 2023 J.P. Morgan Healthcare Conference in January, Samsung Biologics, a fully integrated CDMO offering state...

January 27, 2023 | Friday | News
Lotte Biologics announces $3 B investment plan to leap forward as global CDMO

Lotte Biologics CEO Richard Won-jik Lee has announced a blueprint to leap forward as a global contract development and m...

January 24, 2023 | Tuesday | News
Ajinomoto and Exelixis partner to develop novel antibody-drug conjugates for cancer treatment

Japan-based Ajinomoto has announced a license agreement with US-based firm Exelixis to incorporate AJICAP, Ajinomoto Co....

January 11, 2023 | Wednesday | News